Sarepta Therapeutics (SRPT) Shares on Watch Amid Chatter of Secondary Stock Offering
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Sarepta Therapeutics (Nasdaq: SRPT) shares are on watch amid speculation of an impending secondary stock offering. No official announcement has been made yet.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta's (SRPT) Exondys 51 covered by Humana (HUM) with prior authorization - Bloomberg
- Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
- Sarepta Therapeutics (SRPT) Target of Cautious Article
Create E-mail Alert Related CategoriesEquity Offerings, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!